EE281 Cost-Effectiveness Analysis of Bimekizumab in Patients With Axial Spondyloarthritis (AXSPA) in Greece
Dec 1, 2024, 00:00
10.1016/j.jval.2024.10.563
https://www.valueinhealthjournal.com/article/S1098-3015(24)03426-0/fulltext
Title :
EE281 Cost-Effectiveness Analysis of Bimekizumab in Patients With Axial Spondyloarthritis (AXSPA) in Greece
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)03426-0&doi=10.1016/j.jval.2024.10.563
First page :
Section Title :
Open access? :
No
Section Order :
10055